Verona Pharma ADR (VRNA) Q3 2024 Earnings

4NovConfirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-0.8
-0.59
-0.37
-0.16

Details

Expected EPS
-0.5
Actual EPS
-0.53
Surprise EPS
-0.03
Surprise Percent
+6%

Description

Verona Pharma ADR (VRNA) has reported earnings of -0.53 per share for Q3 2024.

0 Comments

Share your thoughts